In August-September 2017, in Manchester (Great Britain), as in 2016 in the United States, the Institute of Cell Therapy was representing Ukraine at a scientific meeting of the International Federation of Placenta Associations (IFPA). This scientific event is very important for placenta researchers and annually gathers from all over the world leading scientists, doctors, and associates of the biobanking and placental processing industry aimed at manufacturing immunobiological preparations and cosmetic products from it.
Since the lecturers at this conference were placental scientists with a worldwide reputation mainly from the USA, Canada and Great Britain, the inclusion of the work of the Ukrainian scientist-criobiologist Vladimir Shabliy, Ph.D., deputy director of the cryobank of the Institute of Cell Therapy, into the program of a scientific forum of such a high level can be considered as an important achievement not only of our Institute, but also of national science as a whole. This again demonstrates the competitiveness of developments of Ukrainian scientists and trust to the Institute of Cell Therapy.
In addition, the work of the team of authors of the Institute of Cell Therapy under the leadership of VA Shabliy “PLACENTA-DERIVED MULTIPOTENT CELLS EXPRESS SYNCYTIN-1 AND POSSES ABILITY TO FUSE WITH TROPHOBLAST ” took part in the competition for the best scientific work of young researchers and received the Elsevier award.
Protein syncytin, studied by scientists from the Institute of Cell Therapy, plays an important role in the normal course of pregnancy and can have diagnostic value in detecting diseases of the nervous system, etc.
This paper was also published in the prestigious international journal “Placenta” (Placenta, September 2017, vol. 57).
Previously, articles from a series of studies of the Institute of Cell Therapy devoted to the evaluation of the biological properties of the placenta were published in international scientific journals Biomedical Research, Experimental and Therapeutic Medicine, etc. And in 2016, the Institute of Cell Therapy also received an award from IFPA for the series of research on the potential of using placenta stem cells in the treatment of colon cancer, and in 2014 – the Institute of Cell Therapy received an award from the International Placenta Stem Cells Society. From 2013 until now, the Institute of Cell Therapy is a full member of the International Placenta Stem Cells Society.